Trial · NCT03740737
Results by group373
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 373
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cumulative Ongoing Pregnancy Rate After the Fresh Cycle and Cryopreserved Cycles Initiated Within 12 Months From the Start of COS | FE 999049 (Follitropin Delta) | 63.0 | percentage of participants | ||
| Cumulative Ongoing Pregnancy Rate After the Fresh Cycle and Cryopreserved Cycles Initiated Within 12 Months From the Start of COS | Placebo | 0.0 | percentage of participants | ||
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Fresh cycle | 29.5 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | Placebo | Fresh cycle | 0.0 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 65.8 | percentage of participants | |
| Ongoing Pregnancy Rate in the Fresh Cycle and in the Cryopreserved Cycles | Placebo | Cryopreserved cycles | 0 | percentage of participants | |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Total number of days until ongoing pregnancy 12 study months | 133.0 | Standard Deviation 82.5 | days |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles | FE 999049 (Follitropin Delta) | Total number of days until ongoing pregnancy 12 calendar months | 127.6 | Standard Deviation 70.0 | days |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Measured in Number of Cycles Before Achieving Ongoing Pregnancy | FE 999049 (Follitropin Delta) | Number of cycles until ongoing pregnancy 12 study months | 1.8 | Standard Deviation 0.9 | Cycles |
| Time From Start of COS to Ongoing Pregnancy Across the Fresh and Cryopreserved Cycles, Measured in Number of Cycles Before Achieving Ongoing Pregnancy | FE 999049 (Follitropin Delta) | Number of cycles until ongoing pregnancy 12 calendar months | 1.8 | Standard Deviation 0.9 | Cycles |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 49.5 | % of viable fetus/blastocyst transfer | |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 44.2 | % of viable fetus/blastocyst transfer | |
| Ongoing Implantation Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | All cycles | 46.5 | % of viable fetus/blastocyst transfer | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 31.8 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | Fresh cycle | 0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Cryopreserved cycles | 72.3 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | Cryopreserved cycles | 0 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | All cycles | 68.2 | percentage of participants | |
| Clinical Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | Placebo | All cycles | 0 | percentage of participants | |
| Vital Pregnancy Rate in the Fresh Cycle, the Cryopreserved Cycles and Cumulatively | FE 999049 (Follitropin Delta) | Fresh cycle | 30.5 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03740737/results